Frontlight ResearchEarly access
Trial site
Badalona
- 4running trials
- 5closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Chronic myeloid leukaemia3 trials
- Coronary artery disease3 trials
- Stroke3 trials
- Familial hypercholesterolaemia2 trials
- Aortic stenosis1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Heart failure1 trial
- Melanoma1 trial
- Myelodysplastic syndromes1 trial
- Psoriasis1 trial
- Phase
- Phase 36 trials
- Phase 22 trials
- Status
- Completed3 trials
- Active, not recruiting2 trials
- Recruiting2 trials
- Terminated2 trials
- Lead sponsor
- Novartis Pharmaceuticals9 trials
Running trials
Recruiting
A Study to Estimate Secukinumab Retention Rate in Psoriasis Patients With MASLD
Active, not recruiting
Recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Aortic stenosis1 recruiting
- Familial hypercholesterolaemia1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Heart failure1 recruiting
- Psoriasis1 recruiting
Closed trials
Terminated
Completed
Completed
Terminated
Completed
Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)
Site data: ClinicalTrials.govUpdated 15 Nov 2026